Photoelectrochemistry in colloidal systems. Part 2.—A photogalvanic cell based on TiO2 semiconductor colloid
作者:Prashant V. Kamat
DOI:10.1039/f19858100509
日期:——
the standard reduction potential of the dye. The feasibility of employing a colloidal semiconductor system in the operation of a photogalvanic cell is demonstrated. A photogalvanic power conversion efficiency of 0.002% was achieved with thionine and colloidal TiO2 upon bandgap excitation. The use of TiO2 colloid as a carrier for the deposition of a photoactive or an electroactive species on the electrode
Immobilization of components in polymer membrane-based calcium-selective bulk optodes
作者:Thomas. Rosatzin、Petr. Holy、Kurt. Seiler、Bruno. Rusterholz、Wilhelm. Simon
DOI:10.1021/ac00042a004
日期:1992.9.15
A large variety of optical sensors based on thin plasticized PVC membranes have been realized in the past. The organic membrane (bulk optode) contains the analyte recognition molecule such as a selective neutral ionophore, a H+-selective chromolonophore, and lipophilic anionic sites. In order to improve the lifetime of analytically relevant sensing layers, their active components are covalently immobilized to the polymeric matrix. Different Ca2+-selective bulk optodes with mobile or fixed chromolonophores and anionic sites are characterized and discussed with respect to sensor behavior such as dynamic range, repeatability, response time, selectivity, and lifetime. In general, the response time increases upon immobilization of components owing to limited diffusion within the membrane phase, whereas the lifetime is enhanced drastically by a hindered loss of membrane components Into the sample.
BENZOPHENOXAZINE DYES
申请人:Amersham Pharmacia Biotech UK Limited
公开号:EP0885263A1
公开(公告)日:1998-12-23
IMPROVED REAGENT COMPOSITIONS FOR USE IN ELECTROCHEMICAL DETECTION
申请人:NIPRO DIAGNOSTICS, INC.
公开号:EP2245174A2
公开(公告)日:2010-11-03
Reagent Compositions For Use In Electrochemical Detection
申请人:Bell Douglas E.
公开号:US20090186372A1
公开(公告)日:2009-07-23
Biological reagent compositions with improved sensitivity to the concentration of blood glucose in patient samples for use in measuring systems and methods. The reagent compositions comprise a glucose oxidoreductase enzyme, a flavin nucleoside coenzyme and a mediator formulation. The mediator formulation comprises at least one electroactive organic molecule and at least one coordination complex.